SELLAS Life Sciences Group, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $88.0M
Liabilities Breakdown FY2013
Total Liabilities: $82.1M
Asset Breakdown
Total Assets: $88.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $47.8M | 54.3% |
| Accounts Receivable | $3.7M | 4.2% |
| Inventory | $386.0K | 0.4% |
| Property, Plant & Equipment | $665.0K | 0.8% |
| Goodwill | $5.9M | 6.7% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $29.6M | 33.6% |
Liabilities Breakdown
Total Liabilities: $82.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.7M | 3.2% |
| Long-Term Debt | $7.7M | 9.4% |
| Other Liabilities | $71.7M | 87.3% |